Muscle Matters: CMR Tissue Characterization for Mechanistically Tailored Risk Stratification of Functional Mitral Regurgitation.
作者信息
Kim Jiwon, Villar Calle Pablo, Weinsaft Jonathan W
机构信息
Department of Medicine, Division of Cardiology, Weill Cornell Medicine, New York, NY.
出版信息
Circ Cardiovasc Imaging. 2023 Aug;16(8):e015808. doi: 10.1161/CIRCIMAGING.123.015808. Epub 2023 Jul 28.
Abstract
摘要
相似文献
1
Muscle Matters: CMR Tissue Characterization for Mechanistically Tailored Risk Stratification of Functional Mitral Regurgitation.肌肉的重要性：心脏磁共振成像组织特征分析用于功能性二尖瓣反流的机制性个体化风险分层
Circ Cardiovasc Imaging. 2023 Aug;16(8):e015808. doi: 10.1161/CIRCIMAGING.123.015808. Epub 2023 Jul 28.
2
Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.心血管磁共振成像评估瓣膜性心脏病中的心肌纤维化。
Int J Cardiovasc Imaging. 2018 Jan;34(1):97-112. doi: 10.1007/s10554-017-1195-y. Epub 2017 Jun 22.
3
Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation.延迟强化 CMＲ评估二尖瓣装置：梗死分布对二尖瓣反流的相对影响。
JACC Cardiovasc Imaging. 2013 Feb;6(2):220-34. doi: 10.1016/j.jcmg.2012.08.016.
4
Myocardial fibrosis predicts adverse outcome after MitraClip implantation.心肌纤维化可预测二尖瓣夹合术植入后的不良预后。
Catheter Cardiovasc Interv. 2019 May 1;93(6):1146-1149. doi: 10.1002/ccd.27993. Epub 2018 Dec 3.
5
A prospective study examining the role of myocardial Fibrosis in outcome following mitral valve repair IN DEgenerative mitral Regurgitation: rationale and design of the mitral FINDER study.一项前瞻性研究，探讨心肌纤维化在退行性二尖瓣反流二尖瓣修复术后预后中的作用：二尖瓣FINDER研究的原理与设计
BMC Cardiovasc Disord. 2017 Nov 22;17(1):282. doi: 10.1186/s12872-017-0715-y.
6
Mapping of mitral regurgitant defects by cardiovascular magnetic resonance in moderate or severe mitral regurgitation secondary to mitral valve prolapse.心血管磁共振对二尖瓣脱垂继发中重度二尖瓣反流的反流缺损区域进行定位。
J Cardiovasc Magn Reson. 2008 Apr 9;10(1):16. doi: 10.1186/1532-429X-10-16.
7
Percutaneous mitral valve interventions: overview of new approaches.经皮二尖瓣介入治疗：新方法概述。
Curr Cardiol Rep. 2010 Sep;12(5):404-12. doi: 10.1007/s11886-010-0130-9.
8
Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantification.利用心血管磁共振定量测定二尖瓣反流的临床结果
Circulation. 2016 Jun 7;133(23):2287-96. doi: 10.1161/CIRCULATIONAHA.115.017888. Epub 2016 May 17.
9
Importance of Myocardial Fibrosis in Functional Mitral Regurgitation: From Outcomes to Decision-Making.心肌纤维化在功能性二尖瓣反流中的重要性：从结局到决策。
JACC Cardiovasc Imaging. 2021 Apr;14(4):867-878. doi: 10.1016/j.jcmg.2020.10.027. Epub 2021 Feb 10.
10
Results of valve replacement for severe mitral regurgitation due to papillary muscle rupture or fibrosis.
Am J Cardiol. 1973 Sep 7;32(3):313-21. doi: 10.1016/s0002-9149(73)80139-0.
本文引用的文献
1
Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance.心脏磁共振定量评估功能性二尖瓣反流和心肌瘢痕程度的预后价值。
Circ Cardiovasc Imaging. 2023 Aug;16(8):e015134. doi: 10.1161/CIRCIMAGING.122.015134. Epub 2023 Jul 28.
2
Functional Mitral Regurgitation Outcome and Grading in Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭患者的功能性二尖瓣反流结局与分级
JACC Cardiovasc Imaging. 2021 Dec;14(12):2303-2315. doi: 10.1016/j.jcmg.2021.05.017. Epub 2021 Jul 14.
3
Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation.缺血介导的下乳头肌功能障碍作为功能性二尖瓣反流的标志物。
JACC Cardiovasc Imaging. 2021 Apr;14(4):826-839. doi: 10.1016/j.jcmg.2021.01.007. Epub 2021 Mar 17.
4
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
5
2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee.2020 年美国心脏病学会解决方案监督委员会对 2017 年 ACC 专家共识决策路径治疗二尖瓣反流的重点更新：报告
J Am Coll Cardiol. 2020 May 5;75(17):2236-2270. doi: 10.1016/j.jacc.2020.02.005. Epub 2020 Feb 14.
6
Prognostic Impact of Ischemic Mitral Regurgitation Severity and Myocardial Infarct Quantification by Cardiovascular Magnetic Resonance.心血管磁共振对缺血性二尖瓣反流严重程度和心肌梗死定量的预后影响。
JACC Cardiovasc Imaging. 2020 Jul;13(7):1489-1501. doi: 10.1016/j.jcmg.2019.11.008. Epub 2019 Dec 18.
7
Transcatheter Mitral-Valve Repair in Patients with Heart Failure.经导管二尖瓣修复术治疗心力衰竭患者。
N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23.
8
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.经皮修复或药物治疗继发性二尖瓣反流。
N Engl J Med. 2018 Dec 13;379(24):2297-2306. doi: 10.1056/NEJMoa1805374. Epub 2018 Aug 27.
9
Predictors of Mortality in Patients With Severe Ischemic Cardiomyopathy Undergoing Surgical Mitral Valve Intervention.严重缺血性心肌病患者行外科二尖瓣介入治疗的死亡率预测因素。
J Am Heart Assoc. 2017 Nov 17;6(11):e007163. doi: 10.1161/JAHA.117.007163.
10
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.原发性瓣膜反流的非侵入性评估建议：美国超声心动图学会与心血管磁共振学会合作制定的报告
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371. doi: 10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.
Zotero 插件